chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Chest discomfort, Chest pain, Chills, Dyspnoea, Pain
Clinical narrative: High fever; Chills; Body aches; Difficulty breathing; Chest felt like ribs broken; Painful to breath; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7534) via an unspecified route of administration in the left arm on 13Mar2021 at 15:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea and high blood pressure, all since unknown date. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) both for an unknown indication. The patient had no known allergies. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 15Mar2021 at 16:00, reportedly experienced high fever, chills, body aches and difficulty breathing which lasted 11 days, chest felt like he broke ribs and was painful to breath which lasted 6 days. The patient continued to have difficulty breathing which improved daily. On 20Mar2021, the patient underwent nasal swab COVID-19 test and the result was negative. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event painful to breath was recovered on 21Mar2021 after the duration of six days, while the clinical outcome of the events high fever, chills, body aches was recovered on 26Mar2021 after the duration of eleven days. The clinical outcome of the events difficulty breathing and chest felt like ribs broken was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: High fever; Chills; Body aches; Difficulty breathing; Chest felt like ribs broken; Painful to breath; This is a spontaneous report from a contactable consumer, the patient. A 64-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ep7534) via an unspecified route of administration in the left arm on 13Mar2021 at 15:15 (at the age of 64-years-old), as a single dose for COVID-19 immunisation. Medical history included sleep apnea and high blood pressure, all since unknown date. Concomitant medications included losartan (MANUFACTURER UNKNOWN) and loratadine (MANUFACTURER UNKNOWN) both for an unknown indication. The patient had no known allergies. The patient did not receive any other vaccination within four weeks prior to the COVID-19 vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 15Mar2021 at 16:00, reportedly experienced high fever, chills, body aches and difficulty breathing which lasted 11 days, chest felt like he broke ribs and was painful to breath which lasted 6 days. The patient continued to have difficulty breathing which improved daily. On 20Mar2021, the patient underwent nasal swab COVID-19 test and the result was negative. Therapeutic measures were not taken as a result of these events. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the event painful to breath was recovered on 21Mar2021 after the duration of six days, while the clinical outcome of the events high fever, chills, body aches was recovered on 26Mar2021 after the duration of eleven days. The clinical outcome of the events difficulty breathing and chest felt like ribs broken was recovering at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 33.0
Sex: M
Vaccine: COVID19
Symptoms: Rash, Rash vesicular
Clinical narrative: Blistering on the rashes over my right hands and fingers; Rashes [over my right hands and fingers that] are painful to touch.; Right hand had a small rash; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 05Apr2021 at 16:00 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration on an unknown date (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other medications or vaccines within 4 weeks prior to the vaccination. On 05Apr2021 at 16:20, 20 minutes after vaccination the patient experienced a small rash on his right hand. On 07Apr2021, 2 days later it  turned into blistering on the rashes over his right hands and fingers, that were painful to touch. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events right hand had a small rash, blistering on the rashes and rashes painful to touch were not recovered at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 29.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Pyrexia, Vaccination site pain
Clinical narrative: Moderate to severe dizziness; Severe fatigue; Pyrexia; Moderate Pain at IP Site; Mild headache; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 08Apr2021 as a single dose for COVID-19 immunisation. Medical history included COVID-19. Concomitant medications taken within two weeks prior to the vaccination were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in left arm on 18Mar2021, at 13:45 as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 15:30, the patient experienced moderate to severe dizziness, severe fatigue, pyrexia, moderate pain at IP site (coded to vaccination site pain) and mild headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events moderate to severe dizziness, severe fatigue, pyrexia moderate pain at IP site (coded to vaccination site pain) and mild headache was not resolved at the time of report.   No follow-up attempts are needed. No further information is expected.
Age: 80.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swelling on injection site; This is a spontaneous report from a contactable consumer, the patient. An 80-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the right arm on 08Apr2021 at 11:15 (at the age of 80-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none and the patient did not have a history of allergies to any food or medications or other products. The patient did not receive any other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 11:45 within 30 minutes of injection, the patient experienced swelling on injection site. The events did not result in doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. No therapeutic measures were taken for the event. The clinical outcome of the event swelling on injection site was recovering at the time of report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Dyspepsia, Epistaxis, Headache
Clinical narrative: Headache; Chills; Heartburn; Bloody Nose; Sustained Fever of 101-102 for 30 hours starting 12 hours after inoculation; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 06Apr2021 at 11:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 23:30, the patient sustained fever of 101-102 for 30 hours starting 12 hours after inoculation. On 07Apr2021 at 00:00, the patient experienced headache, chills, heartburn and bloody nose. The patient underwent lab tests that included body temperature on 06Apr2021 at 23:30 and the result was 101-102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, chills, heartburn and bloody nose was recovered on an unknown date in Apr2021 and the outcome of the event sustained fever of 101-102 for 30 hours starting 12 hours after inoculation was recovered on 08Apr2021 at 05:30.   No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Headache; Chills; Heartburn; Bloody Nose; Sustained Fever of 101-102 for 30 hours starting 12 hours after inoculation; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 06Apr2021 at 11:30 (at the age of 39-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension. Concomitant medications were not reported. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 16Mar2021 at 11:30 (at the age of 38-years-old), as a single dose for COVID-19 immunisation. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 06Apr2021 at 23:30, the patient sustained fever of 101-102 for 30 hours starting 12 hours after inoculation. On 07Apr2021 at 00:00, the patient experienced headache, chills, heartburn and bloody nose. The patient underwent lab tests that included body temperature on 06Apr2021 at 23:30 and the result was 101-102 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events headache, chills, heartburn and bloody nose was recovered on an unknown date in Apr2021 and the outcome of the event sustained fever of 101-102 for 30 hours starting 12 hours after inoculation was recovered on 08Apr2021 at 05:30.   No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia
Clinical narrative: Sudden loss of taste (especially sweet); This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the arm left on 07Apr2021 at 09:45 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any concomitant medications. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 20:00, the patient experienced sudden loss of taste (especially sweet). The event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of this event. The clinical outcome of the event sudden loss of taste (especially sweet) was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus
Clinical narrative: Full body itching without appearance of rash; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: unknown) via an unspecified route of administration in the left arm on 03Apr2021 at 13:15 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously took latex (MANUFACTURER UNKNOWN), experienced latex allergy and pecans (MANUFACTURER UNKNOWN), experienced food allergy. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 03Apr2021 at 13:45, the patient experienced full body itching without appearance of rash. No therapeutic measures were taken as a result of the reported events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the event full body itching was recovered on an unknown date in Apr2021.  No follow-up attempts are needed; Information about lot/batch number cannot be obtained.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Herpes simplex, Oral herpes, Pyrexia
Clinical narrative: Herpes simplex 1 (fever blisters in nose) from both doses of vaccine; Herpes simplex 1 (fever blisters in nose) from both doses of vaccine; 2nd vaccine causes 102-103 fever for 12 hours; This is a spontaneous report from a contactable other hcp (patient). A 40-year-old (non-pregnant) female patient received second dose of bnt162b2 (BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 31Mar2021 13:45 (at the age of 40-year-old) at dose 2, single for covid-19 immunisation. Medical history was reported as none, patient did not have known allergies, patient was not allergic to medications, food, or other products. Concomitant medication included Estradiol patch .075 (ESTRADIOL) (Other medications the patient received within 2 weeks of vaccination). Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Patient previously received first does of bnt162b2 (BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration, administered in Arm Left on 10Mar2021 13:45 (at the age of 40-year-old) at dose 1, single for covid-19 immunisation, for which patient experienced Herpes simplex 1 (fever blisters in nose) from both doses of vaccine. Patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 01Apr2021 09:00 the patient experienced herpes simplex 1 (fever blisters in nose) from both doses of vaccine on and 2nd vaccine causes 102-103 fever for 12 hours. The patient underwent lab tests and procedures which included fever: 102-103 on 01Apr2021 (2nd vaccine causes 102-103 fever for 12 hours). Patient did not receive treatment for the adverse events. Outcome of the events was resolving.   No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Urinary incontinence
Clinical narrative: left arm pain all the way down arm also; every time I sneeze, I wee wee a little.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure from an unknown duration. The patient did not have allergy to any medications, food, or other products. Concomitant medications included acetylsalicylic acid (aspirin) (MANUFACTURER UNKNOWN), lisinopril (MANUFACTURER UNKNOWN), amlodipine (MANUFACTURER UNKNOWN), paracetamol (TYLENOL), and zolpidem tartrate (AMBIEN); all were taken for unknown indication and within two weeks of the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID -19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 11:00, the patient experienced left arm pain all the way down arm, since got the vaccine, every time when the patient sneeze, the patient urinated down the leg (as reported). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events left arm pain all the way down arm, and wee wee a little on sneezing was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.
Age: 39.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pain in extremity
Clinical narrative: Woke up the next morning ready to puke but stomach was empty; Headache; Fatigue/ Tiredness; Sore arm; This is a spontaneous report from a non-contactable consumer, the patient. A 39-year-old adult of unspecified gender patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 09:15 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included narcolepsy and high blood pressure. The patient received unspecified medication within two weeks of vaccination. The patient has no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced headache, fatigue/tiredness and sore arm which wiped out by early afternoon and on 20Mar2021 next morning she was ready to puke but stomach was empty. The patient did not receive any treatment for the events. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event headache, fatigue and sore arm was resolved on 19Mar2021 and ready to puke but stomach was empty was resolved on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Flushing, Pain in extremity, Pruritus, Rash
Clinical narrative: Having a flushed feeling in face and shoulders; Mild rash on face and shoulders/very fine bumps all over those; Mild sunburn; Feeling itchiness and burning; Feeling itchiness and burning; Think it might just be the crazy amount of pollen in the air; The first two days after the shot had mild chills and soreness in right arm; The first two days after the shot had mild chills and soreness in right arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the arm right on 24Mar2021 at 13:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and penicillin allergy. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the first two days after the shot had mild chills and soreness in right arm. On 06Apr2021, the patient started having a flushed feeling in face and shoulders and now a mild rash on face and shoulders. When it started it felt like a mild sunburn but did not have any signs of sunburn. She can now see very fine bumps all over those areas and had been feeling itchiness and burning. On an unknown date in Apr2021, the patient thought it might just be the crazy amount of pollen in the air, but never experienced any allergy symptoms that affected skin like this and can't think of any other reasons other than possibly the pollen or the vaccine, that's the only reason she felt the need to report. The adverse events did not result in a visit to doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events mild chills and soreness in right arm, pollen allergy, mild sunburn, feeling itchiness and burning, mild rash on face and shoulders/very fine bumps all over those and having a flushed feeling in face and shoulders was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 35.0
Sex: F
Vaccine: COVID19
Symptoms: Seasonal allergy, Skin burning sensation, Sunburn
Clinical narrative: Having a flushed feeling in face and shoulders; Mild rash on face and shoulders/very fine bumps all over those; Mild sunburn; Feeling itchiness and burning; Feeling itchiness and burning; Think it might just be the crazy amount of pollen in the air; The first two days after the shot had mild chills and soreness in right arm; The first two days after the shot had mild chills and soreness in right arm; This is a spontaneous report from a contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8730) via an unspecified route of administration in the arm right on 24Mar2021 at 13:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes and penicillin allergy. Concomitant medications included metformin (MANUFACTURER UNKNOWN) for an unknown indication on an unknown date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021, the first two days after the shot had mild chills and soreness in right arm. On 06Apr2021, the patient started having a flushed feeling in face and shoulders and now a mild rash on face and shoulders. When it started it felt like a mild sunburn but did not have any signs of sunburn. She can now see very fine bumps all over those areas and had been feeling itchiness and burning. On an unknown date in Apr2021, the patient thought it might just be the crazy amount of pollen in the air, but never experienced any allergy symptoms that affected skin like this and can't think of any other reasons other than possibly the pollen or the vaccine, that's the only reason she felt the need to report. The adverse events did not result in a visit to doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of these events. The clinical outcome of the events mild chills and soreness in right arm, pollen allergy, mild sunburn, feeling itchiness and burning, mild rash on face and shoulders/very fine bumps all over those and having a flushed feeling in face and shoulders was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Oropharyngeal pain, SARS-CoV-2 test, Tongue disorder, Transient lingual papillitis
Clinical narrative: Severe sore throat; Painful bumps all over my tongue; Transient lingual papillitis, maybe it is similar to COVID tongue; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 03Apr2021 at 11:30 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 on an unknown. The patient had mild allergy to eggs and peanuts. The patient did not receive any medications within two weeks prior to the vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received penicillin and experienced allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 05Apr2021 at 07:00, within 72 hours of getting the vaccine, the patient experienced severe sore throat, painful bumps all over tongue and transient lingual papillitis. The patient was not sure if it was directly related to the vaccine, but stated might be it was similar to "COVID tongue". Even after 5 days of vaccination the symptoms were ongoing. On 06Apr2021, the patient underwent SARS 2 Ag Point-Of-Care test (POCT) (nasal swab) and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events severe sore throat, painful bumps all over tongue and transient lingual papillitis was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fever; cough; muscle aches; headaches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 07Apr2021 at 09:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included overweight, high blood pressure and chronic breathing issues from COVID-19. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN), telmisartan (MANUFACTURER UNKNOWN) 80 mg and multivitamin (MANUFACTURER UNKNOWN). The patient is not allergic to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had COVID-19 in Dec2020 or Jan2021. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 12:00, the patient felt a mild version of how she felt during her month with COVID-19 and experienced fever, cough, muscle aches, headaches and fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever, cough, muscle aches, headaches and fatigue was resolving at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test
Clinical narrative: Fever; cough; muscle aches; headaches; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8731) via an unspecified route of administration in the right arm on 07Apr2021 at 09:45 (at the age of 59-year-old) as a single dose for COVID-19 immunisation. Medical history included overweight, high blood pressure and chronic breathing issues from COVID-19. Concomitant medications included hydrochlorothiazide (MANUFACTURER UNKNOWN), telmisartan (MANUFACTURER UNKNOWN) 80 mg and multivitamin (MANUFACTURER UNKNOWN). The patient is not allergic to medications, food, or other products. The patient did not receive any medication within two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. The patient had COVID-19 in Dec2020 or Jan2021. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 07Apr2021 at 12:00, the patient felt a mild version of how she felt during her month with COVID-19 and experienced fever, cough, muscle aches, headaches and fatigue. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events fever, cough, muscle aches, headaches and fatigue was resolving at the time of reporting.   No follow-up attempts are possible. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Mass, Pain
Clinical narrative: There is a small painful lump on the bottom of my foot deep in the skin; a small painful lump on the bottom of my foot; This is a spontaneous report from a contactable consumer, the patient. A 42-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 15:45 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension from an unspecified date. Concomitant medications included nebivolol hydrochloride (BYSTOLIC), and warfarin (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW6199) via an unspecified route of administration in the right arm on 10Mar2021 at 13:00 (at the age of 42-years-old) as a single dose for COVID-19 immunisation. The patient previously took vancomycin (MANAFACTURER UNKNOWN) from an unknown date for an unspecified indication and experienced allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 16:15 the patient experienced a small painful lump on the bottom of his foot deep in the skin. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events mass, pain was not recovered.   No follow-up attempts are needed. No further information is expected.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pruritus, Vision blurred, Vomiting
Clinical narrative: Nausea; Vomiting; Itching; Headache; Blurry vision; This is a spontaneous report from a non-contactable healthcare professional, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 06Apr2021 at 12:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included bupropion hydrochloride (WELLBUTRIN) and contraceptives (MANUFACTURER UNKNOWN) both from an unknown date for an unknown indication. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 06Apr2021 at 13:00, the patient experienced nausea, vomiting, itching, headache and blurry vision. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events included treatment with nausea medication. The clinical outcome of the events nausea, vomiting, itching, headache and blurry vision was not recovered at the time of the report.  No follow-up attempts are possible; information about the lot number cannot be obtained.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Full, all-over body pain on the skin, face, hands, feet, legs; Chills; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration at unknown site on 07Apr2021 at 12:30 (at the age of 16-years-old) as a single dose for COVID-19 immunisation. The  patient did not have any relevant medical history. Concomitant medications were not reported. The patient had no known allergies. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration at unknown site on 17Mar2021 at 12:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 08Apr2021 at 01:00, reportedly experienced full, all-over body pain and soreness everywhere from the tip of fingers and toes to the back and neck. Cannot rest or lay on back due to pain in contact with any surface (it was very painful even without contact). It was almost 24 hours after receiving the vaccine and the pain was still as bad as it was last night. The chill has gone away though, but she was complaining of the pain that ADVIL seems not to be able to provide any relief. Therapeutic measures were taken as a result of adverse event pain which included treatment with ADVIL. The adverse events did not result in doctor or other healthcare professional office/clinic visit/ emergency visit. The clinical outcome of the event chills was recovered on 08Apr2021, all-over body pain on the skin, face, hands, feet, legs was not recovered at the time of this report.    No follow-up attempts are needed. No further information is expected.
Age: 30.0
Sex: M
Vaccine: COVID19
Symptoms: Lymphadenopathy, SARS-CoV-2 test
Clinical narrative: Bilateral Swollen cervical(neck) lymph nodes, staying persistently enlarged; This is a spontaneous report from a contactable nurse. A 30-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EL1284) via an unspecified route of administration in the left arm on 22Dec2020 (at the age of 30-years-old) as a single dose for COVID-19 immunisation.  Medical history included allergic to sulfa antibiotics. The patient did not receive any medication within two weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. On 28Dec2020 at 12:00, the patient experienced bilateral swollen cervical(neck) lymph nodes and it was staying persistently enlarged. The patient did not receive any treatment for the reported events. The adverse event resulted in a visit to the doctor or other healthcare professional office/clinic visit and emergency room/department or urgent care. On 31Mar2021, the patient underwent SARS-CoV-2 (nasal swab) test and the result was negative. The clinical outcome of the event bilateral swollen cervical(neck) lymph nodes was not recovered at the time of this report. The patient received the second dose of BNT162b2(PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number: EL3248) ia an unspecified route of administration in the left arm on 12Jan2021(at the age of 30-year-old) as a single dose for COVID-19 immunisation.   No follow-up attempts are needed. No further information is expected.
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Very extreame ringing in the ears; This is a spontaneous report from a contactable consumer (patient).   A 49-year-old male patient received a dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right in Apr2021 (Batch/Lot number was not reported) (at the age of 49-year-old) as single dose for COVID-19 immunisation. Prior to vaccination the patient was diagnosed with COVID-19, other medical history was not reported.  Since the vaccination the patient has not been tested for COVID-19. There were no concomitant medications.  The patient experienced very extreme ringing in the ears in Apr2021 at 15:00. The event required doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of very extreme ringing in the ears and included treatment with steroids. The patient outcome of the event was not recovered.  The lot number for the vaccine, [BNT162B2], was not provided and will be requested during follow up.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Throat irritation
Clinical narrative: Itchy throat; Slight dry cough; Mild difficulty breathing; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 08Apr2021 at 15:45 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included emphysema from an unknown date in 2002 and was ongoing, breast cancer, skin cancer, thyroid cancer, hashimoto's disease and allergy to nuts. Concomitant medication included levothyroxine sodium (SYNTHROID). The patient previously received aspirin (MANUFACTURER UNKNOWN) and experienced drug allergy. The patient also previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11Mar2021 at 15:45 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. The patient had no reaction at all to the first dose of vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 04:15, one half hour after the second dose of vaccination, the patient experienced itchy throat, slight dry cough and mild difficulty breathing. The reaction lasted an hour. The patient stated, if the events had continued or worsened she would have gone to the hospital. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as result of the events. The clinical outcome of the events itchy throat, slight dry cough and mild difficulty breathing were resolved on 08Apr2021 at 05:15. No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: heart palpitations; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Mar2021 (at the age of 28-year-old) as a single dose for COVID-19 immunisation. Medical history included anemia. The patient did not have allergies to medications, food, or other products. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 23Mar2021 the patient experienced heart palpitations, started two days after vaccine and lasted until a week later. The patient was also on period but not sure if that was related. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as the result of adverse events. The clinical outcome of the events heart palpitations was recovered on an unknown date in 2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Thirst, Vaccination site pain
Clinical narrative: Extreme thirst; Injection site pain and soreness; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er2613) via an unspecified route of administration in the left arm on 19Mar2021 at 14:15 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ibuprofen (ADVIL) and paracetamol (TYLENOL); from an unknown date for unknown indication. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19Mar2021 at 17:00, the patient experienced injection site pain and soreness, fatigue and extreme thirst. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of injection site pain and soreness, fatigue and extreme thirst was recovered on an unknown date in 2021.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Hypoaesthesia, Hypoaesthesia oral, Paraesthesia, Throat irritation
Clinical narrative: there was only a 2-inch diameter spot on the right cheek that was still numb.; felt dizziness a few minutes after the vaccine.; cheeks started to tingle about 10-15 minutes after the vaccine; The tingling spread to the rest of my face, then turned to numbness.; The roof of my mouth also became numb; throat started to feel scratchy and bizarre.; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 14:30 (at the age of 53-year-old) as a single dose for COVID-19 immunisation. Medical history included rosacea and allergy to shellfish. Concomitant medications included metronidazole (METROCREAM), riboflavin, magnesium oxide, magnesium citrate and tanacetum parthenium (MIGRELIEF), glucosamine sulfate sodium chloride (DONA GLUCOSAMINE) and calcium gluconate and calcium (MANUFATURER UNKNOWN), all started from an unknown date for unspecified indication. The patient previously took codeine and experienced allergy to it. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 05Apr2021 at 14:45, 10-15 minutes after the vaccination, the patient experienced dizziness, cheeks started to tingle, the tingling spread to the rest of the face, then turned to numbness and the roof of the mouth also became numb. About two hours after the vaccination, the patient experienced throat started to feel scratchy and bizarre. The symptoms started to subside after about 4.5 hours. After 6 hours, the patient experienced a 2-inch diameter spot on the right cheek that was still numb. The events resulted in emergency room/department or urgent care. Therapeutic measures were taken as a result of the events which included treatment with Benadryl 50 mg and the patient was prescribed with EpiPen by the ER staff. The clinical outcome of the events dizziness, cheeks started to tingle, the tingling spread to the rest of the face, then turned to numbness and the roof of the mouth also became numb, throat started to feel scratchy, bizarre and 2-inch diameter spot on the right cheek was recovered on 05Apr2021 at the time of this report.   No follow-up attempts are needed. No further information is expected.